布地奈德混悬液联合异丙托溴铵或特布他林治疗婴儿毛细支气管炎的效果分析  

Efficacy analysis of budesonide suspension combined with ipratropium bromide or terbutaline in the treatment of infant capillary bronchitis

作　　者：黄小红 曾旭华 马远平[1] HUANG Xiao-hong;ZENG Xu-hua;MA Yuan-ping(The People's Hospital of Meizhou,Meizhou,Guangdong 541000)

机构地区：[1]广东省梅州市人民医院儿内二科,广东梅州514000

出　　处：《赣南医学院学报》2019年第3期240-242,261,共4页JOURNAL OF GANNAN MEDICAL UNIVERSITY

摘　　要：目的:探讨布地奈德混悬液分别联合异丙托溴铵或特布他林雾化治疗婴儿毛细支气管炎临床疗效。方法:选择2017年1月～2018年6月梅州市人民医院收治的60例毛细支气管炎的婴儿(≤6个月)为研究对象,按药物使用不同分为观察组和对照组各30例,观察组使用布地奈德混悬液+吸入用异丙托溴铵溶液,对照组使用布地奈德混悬液+特布他林雾化液。比较两组患儿咳嗽、喘息、肺部体征消失时间及住院天数等情况;比较两组患儿药物总有效率。结果:观察组患儿咳嗽、喘息、肺部体征消失时间、住院时间均短于对照组,差异有统计学意义(P <0. 05)。观察组的药物总有效率高于对照组,差异有统计学意义(P <0. 05)。结论:异丙托溴铵联合布地奈德雾化吸入治疗婴儿毛细支气管炎(≤6个月)对比特布他林雾化液联合布地奈德混悬液可相对较快缓解临床症状、缩短病程。Objective:To compare the efficacy of budesonide suspension plus ipratropium bromide with budesonide suspension plus terbutaline in the treatment of infant Capillary bronchitis.Methods:60 patients(no more than 6 months)were included from January 2017 to January 2018 in The People's Hospital of Meizhou.30 cases were treated with budesonide suspension plus ipratropium bromide(observation group),while the other 30 cases were treated with budesonide suspension plus terbutaline(control group).The change of symptoms,signs and length of hospitalization were compared between the two groups.Results:The cough,wheezing,and lung signs relief time and hospitalization time of patients in the observation group were significantly shorter than the control group(all P<0.05).The total effective rate of drugs in the observation group was significantly higher than that in the control group.Conclusions:Ipratropium joint budesonide aerosol inhalation to treat infant capillary bronchitis(6 months or less)contrast Terbutaline fluid of atomization joint budesonide suspension liquid can relatively quickly relieve clinical symptoms,shorten the course of the disease.

关 键 词：布地奈德 异丙托溴铵 特布他林 毛细支气管炎 

分 类 号：R725.6[医药卫生—儿科]